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ABSTRACT 
 
Over the last decades, approaches in designing several lipid carriers have been evolved to deliver the poorly 
soluble drugs. Lipid based systems can play a vital role in improving the efficacy and safety, thus finally 
enhancing the therapeutic efficiency. LBDS can be modified in several ways to meet the wide range of prod-
uct necessities as per the disease condition, product stability and route of administration. Crosslinking of 
polymers or lipids using modern techniques have greatly helped to modulate the specific release of drugs 
and as well safe guard the drug from various enzymes produced in the body thereby increasing the bioavail-
ability greatly. The cross-linking will greatly enable to swell and even allow these varieties of polymers to 
adhere to the natural human tissues, mucosal membranes allowing them to be used for site specific release. 
The review emphasis on different approaches of crosslinking employed for complementing to prepare novel 
drug delivery systems like Emulsions, vesicular system and lipid particulate systems. 
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INTRODUCTION  
Till today, oral route is the most preferred route of 
administration, owing to highest patient compliance, 
greater convenience, reduced cross-
infections/contaminations and economy [1]. 
Conversely, this route is continuously looking into 
newer advances due to the drawbacks associated 
with solubility, poor gastrointestinal absorption, 
larger fluctuations in plasma drug levels and rapid 
metabolism. All these factors may cause for 
unsatisfactory in vivo performance, leading to failure 
of conventional drug delivery systems [2-4]. Many 
significant efforts have been tried for the potential 
application of lipid-based drug delivery systems 
(LBDS), to provide the required site specific 
controlled release of wide range of drugs and 
bioactive agents by improving their solubility. 
Especially, Class II drugs are challenging the 
formulator in view of their bioavailability. LBDS, have 
shown their efficient size dependent properties to 
attract a lot of consideration. There are important few 
points to be considered while formulating LBDS as 
follows, (a) solubility, (b) digestion, (c) dispersion, 
(d) absorption, (e) miscibility, (f) solvent capacity etc 
and also includes morphology at room temperature, 
regulatory issue, purity and chemical stability [5]. 
Several advantages of LBDS are depicted in Figure 1. 
 
Figure 1: Advantages of LBDS 
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These systems are commercially feasible to formulate 
the dosage forms for oral, topical, pulmonary, or 
parenteral delivery. Carrier for LBDS are proved as 
safe and efficient and hence applied to formulate 
several vaccines, nutraceuticals and diagnostics. 
Hence, present review emphasis on design and 
application of LBDS. 
Trends and drawbacks in design and formulation 
of LBDS 
LBDS can be modified in several ways to meet the 
wide range of product necessities as per the disease 
condition, product stability and route of 
administration.  But, at a very early stage of 
development,formulation strategies based on a 
rational and systematicapproach need to be 
developed to avoid erratic and poor invitro/in vivo 
correlations and thus increase the chances of 
successin formulation development. Several useful 
strategies have been published by several authors [6-
10]. LBDS can be classified majorly into Emulsions, 
Vesicular system and Lipid particulate systems.  
Emulsions 
Emulsions are heterogeneous systems of dispersed 
liquid throughout another continuous liquid in the 
form of droplets (droplets size usually exceeding 0.1µ 
diameter). Emulsions are again classified in to 
microemulsion, emulsifying drug delivery systems 
(SEDDS), nano-emulsions and Pickering Emulsions. 
Microemulsion concept was first introduced by Hoar 
and Schulman in 1940 and size was varied from 10-
200 nm. These were evolve between various 
structures in range of swollen micelles to droplets. 
Thermodynamic stability, ease in formulation and 
optical clarity are the few advantages associated with 
microemulsions. SEDDS are mixtures of oil and 
surfactants and sometimes co-solvents, which 
emulsify immediately to produce a fine O/W type of 
emulsion when added to an aqueous phase with 
gentle agitation [11]. 
Recently, SEDDS were formulated using triglyceride 
oils and non ionic surfactants were proved to be less 
toxic. Potential benefits of these systems includes, 
improved bioavailability, more reliable temporal 
profiles of absorption and site specific. 
Nanoemulsions having the size of droplets in range of 
50-1000 nm and formulated with surfactants that are 
approved by GRAS (Generally Recognized as Safe) 
[12].Nanoemulsion can reduce the frequency of 
administration and can guarantee the drug release in 
controlled manner.  
Lipid based emulsions which were stabilized by solid 
particles such as silica, clays, titanium dioxide etc are 
known as  Pickering emulsions. The added sold 
particles will bind to the surface of the interface and 
prevents the droplets from coalescing, which make 
the formulation more stable. In addition, stability of 
Pickering emulsions can be improved by adding 
amphiphilic particles, owing to their high adsorption 
energy.  
Vesicular drug delivery systems 
Several novel vesicular systems were evolved every 
day [13-26]. Drug delivery systems as well as 
biomedical applications of these systems along with 
other microstructures are currently enjoying the 
enormous recognition among the researchers of 
several disciplines. These systems includes 
liposomes, proliposomes, ethosome, phytosome, 
transfersome and niosome  etc [27-59]. 
 
Figure 2: Approaches for LBDS. 
Lipid particulate systems: 
Since few decades, lipids of nanoparticle and 
microparticle were evolved as potential polymeric 
carriers due to their size dependant properties. Few 
advantageous characters of these systems includes, 
• Higher levels of drug targeting,  
• Controlled drug release, 
• Physiologically compatible and stable, 
• Ease of technology transfer to large scale, 
• Protection of active ingredient,  
• Matrix is composed of well tolerable lipids.  
• High stability.  
These systems comprises of lipospheres, lipid drug 
conjugates, solid lipid nanoparticles and 
microparticles. Despite of all these merits, LBDS have 
few limitations with respect to gastric retention 
especially for the drug which are having the 
absorption window in the upper GIT. Thus, can 
encounter with the less bioavailability and 
absorption. Hence to overcome this several cross 
linking techniques were incorporated to enhance the 
gastric retention either gastric retention approaches.  
Application of mucoadhesion technologies 
Application of mucoadhesive systems or cross linking 
with other related polymers can also improve the 
residence of dosage form in the absorption site [60] 
Mucoadhesive polymers have to enhance the contact 
with mucus membrane by forming strong covalent 
bonds. Thiolation is one of the approach to improve 
mucoadhesion property of several natural and 
synthetic polymer [61,62]. Thiolated LBDS are proved 
as efficient in improving the bioavailability of several 
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insoluble drugs, which are having the absorption 
window in the stomach [63-67]. Response surface 
methodology can be applied successfully to study the 
interaction of independent factors [68].   
Future prospective and conclusion 
There is a need to consider more about the 
characteristics of various lipid formulations, so that 
experimental conditions and guidelines can be 
established. More technologies to be applied for the 
identification of suitable candidates at early stages. 
Attention to several physical and chemical stability 
issues of drug in the lipid systems. There a need to 
seek the tracking of solubilization of drug in in-vivo 
conditions. Despite the fact that these present 
challenges, there is a great potential in the use of lipid 
formulations. The safety of the different nano-
delivery carriers following uptake needs to be 
explored further. Studies focused on the 
nanotoxicology of these delivery systems in human 
skin have been limited, especially with the newer 
classes, and is likely to vary according to the 
composition and size of the vesicles. Finally, LBDS are 
physiologically well tolerated class of systmes, which 
provides a vast array of possibilities to formulate and 
potentially increase the bioavailability of poorly 
soluble drugs. 
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